Nigel Irwin

6.7k total citations
221 papers, 5.5k citations indexed

About

Nigel Irwin is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cellular and Molecular Neuroscience. According to data from OpenAlex, Nigel Irwin has authored 221 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 168 papers in Endocrinology, Diabetes and Metabolism, 120 papers in Surgery and 98 papers in Cellular and Molecular Neuroscience. Recurrent topics in Nigel Irwin's work include Diabetes Treatment and Management (147 papers), Pancreatic function and diabetes (113 papers) and Neuropeptides and Animal Physiology (95 papers). Nigel Irwin is often cited by papers focused on Diabetes Treatment and Management (147 papers), Pancreatic function and diabetes (113 papers) and Neuropeptides and Animal Physiology (95 papers). Nigel Irwin collaborates with scholars based in United Kingdom, France and United States. Nigel Irwin's co-authors include Peter R. Flatt, Victor A. Gault, Finbarr O’Harte, R. Charlotte Moffett, Brian D. Green, Paula L. McClean, Guillaume Mabilleau, Daniel Chappard, Patrick Harriott and Ryan A. Lafferty and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Nigel Irwin

217 papers receiving 5.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nigel Irwin United Kingdom	40	3.6k	2.5k	2.0k	1.7k	953	221	5.5k
Masaki Hosoya Japan	25	1.0k 0.3×	3.0k 1.2×	1.8k 0.9×	2.9k 1.8×	563 0.6×	35	6.6k
Shoji Fukusumi Japan	26	928 0.3×	2.6k 1.1×	1.5k 0.8×	2.5k 1.5×	523 0.5×	33	6.4k
Yugo Habata Japan	23	888 0.2×	2.6k 1.1×	1.5k 0.8×	2.5k 1.5×	481 0.5×	31	5.9k
Jonathan E. Campbell Canada	26	1.9k 0.5×	1.2k 0.5×	1.0k 0.5×	383 0.2×	909 1.0×	40	3.3k
Yuji Kawamata Japan	19	816 0.2×	2.6k 1.0×	1.2k 0.6×	2.2k 1.3×	440 0.5×	29	5.8k
Anthony L. Albiston Australia	33	1.7k 0.5×	534 0.2×	2.0k 1.0×	1.1k 0.7×	312 0.3×	72	4.4k
Dominic P. Behan United States	31	1.6k 0.4×	598 0.2×	1.1k 0.6×	823 0.5×	686 0.7×	60	4.4k
Kristoffer L. Egerod Denmark	30	741 0.2×	778 0.3×	1.5k 0.8×	535 0.3×	1.0k 1.1×	50	3.4k
Kenju Shimomura Japan	32	909 0.3×	1.2k 0.5×	1.3k 0.7×	227 0.1×	601 0.6×	122	3.5k
Hail Kim South Korea	33	795 0.2×	1.2k 0.5×	1.5k 0.8×	266 0.2×	916 1.0×	82	3.8k

Countries citing papers authored by Nigel Irwin

Since Specialization

Citations

This map shows the geographic impact of Nigel Irwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel Irwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel Irwin more than expected).

Fields of papers citing papers by Nigel Irwin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nigel Irwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel Irwin. The network helps show where Nigel Irwin may publish in the future.

Co-authorship network of co-authors of Nigel Irwin

This figure shows the co-authorship network connecting the top 25 collaborators of Nigel Irwin. A scholar is included among the top collaborators of Nigel Irwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nigel Irwin. Nigel Irwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tanday, Neil, et al.. (2025). The Beneficial Impact of a Novel Pancreatic Polypeptide Analogue on Islet Cell Lineage. International Journal of Molecular Sciences. 26(9). 4215–4215. 2 indexed citations

Flatt, Peter R., et al.. (2024). Dopamine signalling in pancreatic islet cells and role in adaptations to metabolic stress. Journal of Pharmacy and Pharmacology. 76(7). 861–872. 2 indexed citations

Lafferty, Ryan A., Peter R. Flatt, Victor A. Gault, & Nigel Irwin. (2024). Does glucose-dependent insulinotropic polypeptide receptor blockade as well as agonism have a role to play in management of obesity and diabetes?. Journal of Endocrinology. 262(2). 3 indexed citations

Lafferty, Ryan A., Peter R. Flatt, & Nigel Irwin. (2023). GLP-1/GIP analogs: potential impact in the landscape of obesity pharmacotherapy. Expert Opinion on Pharmacotherapy. 24(5). 587–597. 36 indexed citations

Tanday, Neil, et al.. (2023). A novel peptide isolated from Aphonopelma chalcodes tarantula venom with benefits on pancreatic islet function and appetite control. Biochemical Pharmacology. 212. 115544–115544. 4 indexed citations

Khan, Dawood, Jessie A. Elliott, Violetta Naughton, et al.. (2023). RYGB surgery has modest effects on intestinal morphology and gut hormone populations in the bypassed biliopancreatic limb but causes reciprocal changes in GLP-2 and PYY in the alimentary limb. PLoS ONE. 18(5). e0286062–e0286062. 2 indexed citations

Tanday, Neil, et al.. (2023). Sex-based impact of pancreatic islet stressors in GluCreERT2/Rosa26-eYFP mice. Journal of Endocrinology. 259(2). 5 indexed citations

Lafferty, Ryan A., et al.. (2022). Sustained glucagon receptor antagonism in insulin-deficient high-fat-fed mice. Journal of Endocrinology. 255(2). 91–101. 5 indexed citations

Flatt, Peter R., et al.. (2021). Weight‐reducing, lipid‐lowering and antidiabetic activities of a novel arginine vasopressin analogue acting at the V1a and V1b receptors in high‐fat‐fed mice. Diabetes Obesity and Metabolism. 23(10). 2215–2225. 7 indexed citations

10.

Gault, Victor A., et al.. (2021). A novel neurotensin/xenin fusion peptide enhances β-cell function and exhibits antidiabetic efficacy in high-fat fed mice. Bioscience Reports. 41(8). 1 indexed citations

11.

Tanday, Neil, R. Charlotte Moffett, Victor A. Gault, Peter R. Flatt, & Nigel Irwin. (2020). Enzymatically stable analogue of the gut‐derived peptide xenin on beta‐cell transdifferentiation in high fat fed and insulin‐deficient Ins1^Cre/+;Rosa26‐eYFP mice. Diabetes/Metabolism Research and Reviews. 37(3). e3384–e3384. 9 indexed citations

12.

Tanday, Neil, Nigel Irwin, R. Charlotte Moffett, Peter R. Flatt, & Finbarr O’Harte. (2020). Beneficial actions of a long‐acting apelin analogue in diabetes are related to positive effects on islet cell turnover and transdifferentiation. Diabetes Obesity and Metabolism. 22(12). 2468–2478. 24 indexed citations

13.

Hasib, Annie, Dawood Khan, Stephen L. Craig, et al.. (2019). Antidiabetic effects and sustained metabolic benefits of sub-chronic co-administration of exendin-4/gastrin and xenin-8-Gln in high fat fed mice. European Journal of Pharmacology. 865. 172733–172733. 1 indexed citations

14.

Mieczkowska, A., et al.. (2019). GIP analogues augment bone strength by modulating bone composition in diet-induced obesity in mice. Peptides. 125. 170207–170207. 24 indexed citations

15.

Moffett, R. Charlotte, Victor A. Gault, Neil Tanday, et al.. (2019). Effects of long-acting GIP, xenin and oxyntomodulin peptide analogues on alpha-cell transdifferentiation in insulin-deficient diabetic GluCreERT2;ROSA26-eYFP mice. Peptides. 125. 170205–170205. 26 indexed citations

16.

Lafferty, Ryan A., Peter R. Flatt, & Nigel Irwin. (2018). C-terminal degradation of PYY peptides in plasma abolishes effects on satiety and beta-cell function. Biochemical Pharmacology. 158. 95–102. 21 indexed citations

17.

Mieczkowska, A., et al.. (2018). Sitagliptin Alters Bone Composition in High-Fat-Fed Mice. Calcified Tissue International. 104(4). 437–448. 21 indexed citations

18.

Mieczkowska, A., Peter R. Flatt, Béatrice Bouvard, et al.. (2016). A new stable GIP–Oxyntomodulin hybrid peptide improved bone strength both at the organ and tissue levels in genetically-inherited type 2 diabetes mellitus. Bone. 87. 102–113. 31 indexed citations

19.

Mabilleau, Guillaume, Rodolphe Perrot, Peter R. Flatt, Nigel Irwin, & Daniel Chappard. (2016). High fat-fed diabetic mice present with profound alterations of the osteocyte network. Bone. 90. 99–106. 37 indexed citations

20.

Green, BD, Victor A. Gault, MH Mooney, et al.. (2004). Molecular, cellular and biological characteristics of DPP IV-resistant acetylated analogues of GLP-1.. Diabetic Medicine. 21. 26–26. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact